[Alternatives to digitalis therapy: metabolic aspects].
D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001337:Autonomic Agents / Q000627:therapeutic use; D003285:Contractile Proteins / Q000378:metabolism; D004071:Digitalis Glycosides / Q000378:metabolism* / Q000627:therapeutic use; D004734:Energy Metabolism; D005934:Glucagon / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009206:Myocardium / Q000378:metabolism*; D009566:Nitrates / Q000627:therapeutic use; D009603:Nitroso Compounds / Q000627:therapeutic use; D010725:Phosphocreatine / Q000378:metabolism; D012083:Renin / Q000378:metabolism
D001337:Autonomic Agents; D003285:Contractile Proteins; D004071:Digitalis Glycosides; D007328:Insulin; D009566:Nitrates; D009603:Nitroso Compounds; D010725:Phosphocreatine; D000804:Angiotensin II; D000450:Aldosterone; D005934:Glucagon; D012083:Renin; D005947:Glucose
Alternativen zur Digitalistherapie: Metabolische Aspekte.